GLRX2 and cancer: Reciprocally, we also identified few genes which become activated concomitantly with DNA hypomethylation following WA treatment, such as genes involved in L-cysteine and redox metabolism i.e. glutaredoxin 2 (GLRX2) and glutamine-fructose-6-phosphate transaminase 2 (GFPT2), syntaxin11 (STX11) involved in vesicular trafficking, and inducible nerve growth factor (VGF) involved in suppression of cancer progression and metastasis [47, 48].